Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | BCL2 | P10415 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22341413 | 0.81 | ALDH1A1 (0.43) | ALDH1A1TSHRLMNAL3MBTL1 | |
| SCHEMBL31276299 | 0.75 | DNM1 (0.33) | ALDH1A1TSHRDNM1 | |
| SCHEMBL17030340 | 0.75 | ALDH1A1 (0.44) | ALDH1A1TSHRL3MBTL1 | |
| SCHEMBL1853215 | 0.73 | ALDH1A1 (0.38) | ALDH1A1TSHRLMNAL3MBTL1 | |
| SCHEMBL18918047 | 0.73 | ALDH1A1 (0.36) | ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL27848826 | 0.73 | ALDH1A1 (0.44) | ALDH1A1 | |
| SCHEMBL14737887 | 0.73 | ALDH1A1 (0.42) | ALDH1A1TSHRL3MBTL1 | |
| SCHEMBL1857359 | 0.73 | ALDH1A1 (0.36) | ALDH1A1L3MBTL1 | |
| SCHEMBL6185698 | 0.73 | ALDH1A1 (0.48) | ALDH1A1TSHRLMNAL3MBTL1 | |
| SCHEMBL3242414 | 0.72 | ALDH1A1 (0.39) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2341886-B1 | ANTIMICROBIAL N-CHLORINATED COMPOSITIONS | NOVABAY PHARMACEUTICALS INC (US) | 2015-08-26 | — | — | EP | disclosed |
| US-8278482-B2 | Antimicrobial N-chlorinated compositions | NOVABAY PHARMACEUTICALS, INC. (US) | 2012-10-02 | — | — | US | disclosed |
| US-20100158818-A1 | ANTIMICROBIAL N-CHLORINATED COMPOSITIONS | NOVABAY PHARMACEUTICALS, INC. | 2010-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100158818-A1 | ANTIMICROBIAL N-CHLORINATED COMPOSITIONS | NRDC, NHERF1, MPO | ALDH1A1 3343/4885TSHR 1073/4885LMNA 3454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.